Publications by authors named "Tesfamariam Aklilu Betemariam"
Purpose Of Review: This review summarises the shifting paradigms in the treatment of ischemic left ventricular dysfunction, spotlighting the revascularization for ischemic ventricular dysfunction-British cardiovascular intervention society-2 (REVIVED-BCIS2) trial results and its impact on key therapeutic goals: survival, left ventricular function, arrhythmia prevention, quality of life and viability testing.
Recent Findings: The REVIVED-BCIS2 trial, and its subsequent sub studies highlighted that (PCI) does not provide additional benefits to optimal medical therapy in terms of improving survival, left ventricular (LV) function, arrhythmic risk or quality of life. Additionally, viability testing did not differentiate patients who could benefit from PCI, although scar burden was found to be a significant predictor of outcome in these patients.
Article Synopsis
- Congenital myelomeningocele, or spina bifida, is the most common birth defect affecting the central nervous system, impacting neonatal survival and long-term quality of life in children.
- A study conducted at Zewditu Memorial Hospital in Ethiopia assessed the health-related quality of life (HRQoL) in 232 children with spina bifida using a standardized questionnaire from June to September 2022.
- Results showed a median age of 5 years, with overall HRQoL scores indicating challenges in school participation, while factors like family income and neurogenic bladder significantly influenced quality of life outcomes.